77583

Dereplication of Jurubatiba restinga plant extracts with cardiovascular activity

Favorite this paper

Cardiovascular diseases (CVD) are a major public health issue, being responsible for a great number of deaths worldwide yearly. Related to that, hypertension complications accounts for more than 50% of the deaths caused by CVDs, and worse, have limited treatments. Natural products play an important role in the discovery of new chemical entities (NCE) with pharmacological effects, because a small part, of the whole potential, of the natural products was studied. However, simply prospection of natural products may not lead to any significant discovery. This happens because of two factors: first, the research could lead to compounds already discovered in other organisms; second, it could lead to new compounds, but somewhat similar to one already known, so with no new activity. So, the dereplication was created to solve this problem, with the help of modern analytical techniques, like LC-MS and NMR. Thus, the aim of this work will be the dereplication of five plant species present in the Jurubatiba restinga (Kielmeyera membranacea, VItex polygama, Tapirira guianensis, Mandevilla moricandiana, and Stachytarpheta schottiana) in search of New Chemical Entities (NCE) with cardiovascular activity. Some of this plants extracts have demonstrated significant cardiovascular activity, described by the research team of Laboratório de Produtos Bioativos (LPBio), like the Mandevilla moricandianaand Tapirira guianensis. The plant species were collected in the resting at the same day. Then, they were processed, extracted with ethanol and dried in the rotatory evaporator to obtain the crude extract. In the next step, the crude extracts will be micro-fractionated with solvents in crescent polarity order (hexane, dichloromethane, ethyl acetate and methanol). The hexane and dichloromethane extracts will be analyzed by GC-MS, while the more polar extracts, ethyl acetate and methanol, will be analyzed be LC-MS. These analyses will be processed under rigorous statistical parameters, allowing the results to be obtained with a high degree of significance and, so, guaranteeing that the results are reliable for dereplication. The GC-MS analyses will be conducted with Helium as flow gas and a DB5 fused-silica capillary column, while the LC-MS will be conducted using linked-silica phases with complimentary selectivity, such as, biphenyl and C18 columns, packed with core-shell particles to enhance the separation efficiency and selectivity. The LC-MS method will be developed as a solvent gradient, using ultra-pure water acidified with formic acid and acetonitrile as mobile phase, and the GC-MS method will use a temperature ramp to assure the proper separation and identification of the compounds. These methods will allow identifying the known compounds, and focusing on the novel ones. So far, the crude extracts from all plants have been prepared, while the micro-fractionations were carried out for Kielmeyera membranacea and Vitex polygama. Up to now, Kielmeyera membranacea ethyl acetate and methanol fractions have been analyzed by LC-MS. Further, the promising extracts will be fractionated by counter-current chromatography, and the pure compounds being analyzed by NMR.